TrueCar, Inc.
TrueCar, Inc. (TRUE) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for TrueCar, Inc. (TRUE), featuring income statements, balance sheets, and cash flow data.
TrueCar, Inc. (TRUE) Income Statement & Financial Overview
Access detailed annual and quarterly income data for TrueCar, Inc. TRUE financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $44.81M | $46.21M | $46.54M | $41.80M |
Cost of Revenue | $8.89M | -$362000.00 | $7.74M | $10.17M |
Gross Profit | $35.92M | $46.57M | $38.81M | $31.63M |
Gross Profit Ratio | $0.80 | $1.008 | $0.83 | $0.76 |
R&D Expenses | $8.12M | $6.91M | $7.18M | $7.43M |
SG&A Expenses | $35.10M | $33.15M | $34.61M | $39.38M |
Operating Expenses | $47.12M | $53.78M | $46.20M | $46.82M |
Total Costs & Expenses | $56.008M | $53.42M | $53.93M | $56.98M |
Interest Income | $1.07M | $1.27M | $1.56M | $1.67M |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $4.24M | $4.69M | $4.75M | $4.68M |
EBITDA | -$6.96M | -$2.43M | -$2.64M | -$8.83M |
EBITDA Ratio | -$0.16 | -$0.05 | -$0.06 | -$0.21 |
Operating Income | -$11.20M | -$7.12M | -$7.39M | -$15.19M |
Operating Income Ratio | -$0.25 | -$0.15 | -$0.16 | -$0.36 |
Other Income/Expenses (Net) | $1.07M | $1.27M | $1.56M | $1.67M |
Income Before Tax | -$10.13M | -$5.85M | -$5.83M | -$13.52M |
Income Before Tax Ratio | -$0.23 | -$0.13 | -$0.13 | -$0.32 |
Income Tax Expense | $6000.00 | $2000.00 | $3000.00 | $3000.00 |
Net Income | -$10.14M | -$5.85M | -$5.83M | -$13.52M |
Net Income Ratio | -$0.23 | -$0.13 | -$0.13 | -$0.32 |
EPS | -$0.12 | $0.28 | -$0.06 | -$0.15 |
Diluted EPS | -$0.12 | $0.28 | -$0.06 | -$0.15 |
Weighted Avg Shares Outstanding | $87.31M | $87.19M | $90.32M | $91.85M |
Weighted Avg Shares Outstanding (Diluted) | $87.31M | $87.19M | $90.32M | $91.85M |
The company's financials show resilient growth, with revenue advancing from $41.80M in Q2 2024 to $44.81M in Q1 2025. Gross profit remained healthy with margins at 80% in Q1 2025 compared to 76% in Q2 2024. Operating income hit -$11.20M last quarter, sustaining a consistent -25% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$6.96M. Net income dropped to -$10.14M, while earnings per share reached -$0.12. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan